<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02162316</url>
  </required_header>
  <id_info>
    <org_study_id>HyFu</org_study_id>
    <nct_id>NCT02162316</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Efficacy Between Helicobacter Pylori Eradication Therapy and Motilitone in Functional Dyspepsia</brief_title>
  <official_title>A Multicenter, Randomized, Double-blind Comparative Study to Evaluate the Efficacy Between Helicobacter Pylori Eradication Therapy and Motilitone in Functional Dyspepsia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chung-Ang University Hosptial, Chung-Ang University College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chung-Ang University Hosptial, Chung-Ang University College of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a clinical study to evaluate the efficacy between Helicobacter pylori Eradication
      therapy and Motilitone in Functional Dyspepsia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter, randomized, double-blind comparative clinical study to evaluate the
      efficacy between Helicobacter pylori Eradication therapy and Motilitone in Functional
      Dyspepsia
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Volunteer global assessment of improvement rate of functional dyspepsia by using 5-Likert scale</measure>
    <time_frame>12 weeks</time_frame>
    <description>5-Likert scale
deteriorated
not changed
moderately improved
markedly improved
symptom-free</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Volunteer global assessment by using 5-Likert scale</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The improvement rate of 4 types of dyspepsia symptoms</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of each score and total score of dyspeptic symptoms</measure>
    <time_frame>6, 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of NDI-K Quality of Life</measure>
    <time_frame>6,12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The proportion of the patients who answered &quot;yes for the question about symptom improvement</measure>
    <time_frame>6, 12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">136</enrollment>
  <condition>Functional Dyspepsia</condition>
  <arm_group>
    <arm_group_label>H.Pylori eradication therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A-cillin®, Pantoline® and Clari® is administered with a tablet of placebo (Motilitone®)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Motilitone®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 mg is administered with 3 tablets of placebo (Patoline®, Clari® and A-cilin)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Motilitone®</intervention_name>
    <arm_group_label>Motilitone®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>A-Cilin®, Clari® and Pantoline®</intervention_name>
    <arm_group_label>H.Pylori eradication therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Roman III criteria

          -  One or more conditions are applied: epigastric pain, epigastric burning, bothersome,
             postprandial fullness or early satiety

          -  No organic lesion

          -  Helicobacter pylori infection

        Exclusion Criteria:

          -  has taken prokinetics, H2 antagonists, PPIs, NSAIDs, anticholinergics, antibiotics,
             antidepressants, anticoagulants within a month

          -  had a surgery that might affect gastrointestinal motility
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Su Jin Hong, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Soonchunhyang University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gwang Ha Kim, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Busan National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sang Gyun Kim, M.D., Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hyun Soo Kim, M.D., Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chonnam National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seong-Woo Jeon, M.D., Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyungpook National University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jae Gyu Kim, M.D., Ph.D</last_name>
    <phone>82-2-6299-3147</phone>
    <email>jgkimd@cau.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chung-Ang University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jae Gyu Kim, M.D., Ph.D</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 11, 2014</study_first_submitted>
  <study_first_submitted_qc>June 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2014</study_first_posted>
  <last_update_submitted>June 23, 2014</last_update_submitted>
  <last_update_submitted_qc>June 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chung-Ang University Hosptial, Chung-Ang University College of Medicine</investigator_affiliation>
    <investigator_full_name>Jae Gyu Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyspepsia</mesh_term>
    <mesh_term>Gastritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

